Ping An Biomedical Co., Ltd. (PASW)

NASDAQ: PASW · Real-Time Price · USD

0.1383

+0.0037 (2.75%)

At close: Sep 18, 2026, 4:00 PM EDT

0.1330

-0.0053 (-3.83%)

After-hours: Sep 18, 2026, 6:01 PM EDT

Ping An Biomedical Balance Sheet

Financials in millions CNY. Fiscal year is October - September.

Millions CNY. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	6.84	1.17	0.13	0.59	1.17	0.11
Short-Term Investments	13.74	-	-	-	0.07	-
Cash & Short-Term Investments	20.58	1.17	0.13	0.59	1.23	0.11
Cash Growth	18666.49%	795.55%	-77.88%	-52.01%	1066.71%	-33.40%
Accounts Receivable	6.19	16.93	40.44	47.09	57	49.02
Other Receivables	-	0.31	0.07	0.07	0.03	0.76
Receivables	6.19	17.25	40.51	47.16	57.03	49.78
Inventory	-	0.44	0.13	3.19	4.63	16.01
Restricted Cash	29.14	35.52	-	-	-	-
Other Current Assets	-	9.31	12.54	25.63	16.15	4.47
Total Current Assets	55.91	63.7	53.31	76.57	79.04	70.36
Property, Plant & Equipment	0.27	0.47	0.82	0.54	0.18	0.57
Long-Term Deferred Tax Assets	2.79	4.25	2.72	2.73	2.72	2.77
Total Assets	100.22	68.41	56.85	79.84	81.95	73.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	1.62	9.41	15.06	9.27	18.04	7.14
Accrued Expenses	7.11	0.27	0.56	0.82	1.77	0.27
Short-Term Debt	10	10	10	42.5	56.1	60.74
Current Portion of Leases	0.27	0.37	0.35	0.39	0.07	0.39
Current Income Taxes Payable	-	-	0.33	-	1.08	0.64
Current Unearned Revenue	-	0.07	1.67	0.53	0.27	1.67
Other Current Liabilities	3.04	2.95	35.61	32.12	0.02	4.85
Total Current Liabilities	22.04	23.08	63.58	85.63	77.35	75.7
Long-Term Leases	-	0.1	0.46	0.07	-	0.07
Total Liabilities	22.04	23.17	64.04	85.7	77.35	75.77

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	0.05	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	107.75	66.21	-	-	-	0
Retained Earnings	-14.54	-19.37	-6.54	-4.94	5.66	-1.57
Comprehensive Income & Other	-15.08	-1.61	-0.66	-0.93	-1.07	-0.5
Shareholders' Equity	78.18	45.24	-7.19	-5.86	4.6	-2.06
Total Liabilities & Equity	100.22	68.41	56.85	79.84	81.95	73.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Total Debt	10.27	10.47	10.81	42.96	56.16	61.2
Net Cash (Debt)	10.3	-9.3	-10.68	-42.36	-54.93	-61.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.30	-0.50	-0.59	-2.35	-3.05	-3.39
Filing Date Shares Outstanding	125.12	24.55	18	18	18	18
Total Common Shares Outstanding	125.12	20.5	18	18	18	18
Working Capital	33.87	40.62	-10.27	-9.06	1.69	-5.34
Book Value Per Share	0.62	2.21	-0.40	-0.33	0.26	-0.11
Tangible Book Value	78.18	45.24	-7.19	-5.86	4.6	-2.06
Tangible Book Value Per Share	0.62	2.21	-0.40	-0.33	0.26	-0.11
Machinery	-	0.1	0.1	0.1	0.1	0.07